IL150392A0 - Novel esters derived from (rr, ss)-2-(hydroxbenzoate of 3-(2-dimethylaminomethyl-1-hydroxyclohexyl) phenyl - Google Patents
Novel esters derived from (rr, ss)-2-(hydroxbenzoate of 3-(2-dimethylaminomethyl-1-hydroxyclohexyl) phenylInfo
- Publication number
- IL150392A0 IL150392A0 IL15039200A IL15039200A IL150392A0 IL 150392 A0 IL150392 A0 IL 150392A0 IL 15039200 A IL15039200 A IL 15039200A IL 15039200 A IL15039200 A IL 15039200A IL 150392 A0 IL150392 A0 IL 150392A0
- Authority
- IL
- Israel
- Prior art keywords
- hydroxyclohexyl
- hydroxbenzoate
- dimethylaminomethyl
- phenyl
- esters derived
- Prior art date
Links
- 150000002148 esters Chemical class 0.000 title 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C219/00—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton
- C07C219/26—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
- C07C219/28—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton having amino groups bound to acyclic carbon atoms of the carbon skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ES200000060A ES2160534B1 (es) | 1999-12-30 | 1999-12-30 | Nuevos esteres derivados de (rr,ss)-2-hidroxibenzoato de 3-(2-dimetilaminometil-1-hidroxiciclohexil) fenilo. |
| PCT/ES2000/000486 WO2001049650A1 (fr) | 1999-12-30 | 2000-12-26 | Nouveaux esters derives de (rr,ss)-2-hydroxybenzoate de 3-(2-dimethylaminomethyl-1-hydroxycyclohexyl)phenyle |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL150392A0 true IL150392A0 (en) | 2002-12-01 |
Family
ID=8491916
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL15039200A IL150392A0 (en) | 1999-12-30 | 2000-12-26 | Novel esters derived from (rr, ss)-2-(hydroxbenzoate of 3-(2-dimethylaminomethyl-1-hydroxyclohexyl) phenyl |
Country Status (30)
| Country | Link |
|---|---|
| US (1) | US6894076B2 (fr) |
| EP (1) | EP1251120B1 (fr) |
| JP (1) | JP2003519208A (fr) |
| KR (1) | KR20020063281A (fr) |
| CN (1) | CN1414946A (fr) |
| AP (1) | AP1234A (fr) |
| AT (1) | ATE284380T1 (fr) |
| AU (1) | AU775918B2 (fr) |
| BG (1) | BG106883A (fr) |
| BR (1) | BR0016882A (fr) |
| CA (1) | CA2395976A1 (fr) |
| CZ (1) | CZ20022189A3 (fr) |
| DE (1) | DE60016631D1 (fr) |
| EA (1) | EA004770B1 (fr) |
| EE (1) | EE200200365A (fr) |
| ES (1) | ES2160534B1 (fr) |
| HR (1) | HRP20020559A2 (fr) |
| HU (1) | HUP0204147A3 (fr) |
| IL (1) | IL150392A0 (fr) |
| IS (1) | IS6440A (fr) |
| MA (1) | MA26862A1 (fr) |
| MX (1) | MXPA02006514A (fr) |
| NO (1) | NO20023098L (fr) |
| NZ (1) | NZ520263A (fr) |
| OA (1) | OA12132A (fr) |
| PL (1) | PL356056A1 (fr) |
| SK (1) | SK9252002A3 (fr) |
| WO (1) | WO2001049650A1 (fr) |
| YU (1) | YU50902A (fr) |
| ZA (1) | ZA200205193B (fr) |
Families Citing this family (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7776314B2 (en) | 2002-06-17 | 2010-08-17 | Grunenthal Gmbh | Abuse-proofed dosage system |
| US20070048228A1 (en) | 2003-08-06 | 2007-03-01 | Elisabeth Arkenau-Maric | Abuse-proofed dosage form |
| DE10336400A1 (de) | 2003-08-06 | 2005-03-24 | Grünenthal GmbH | Gegen Missbrauch gesicherte Darreichungsform |
| DE10361596A1 (de) | 2003-12-24 | 2005-09-29 | Grünenthal GmbH | Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform |
| DE102005005446A1 (de) | 2005-02-04 | 2006-08-10 | Grünenthal GmbH | Bruchfeste Darreichungsformen mit retardierter Freisetzung |
| US8075872B2 (en) | 2003-08-06 | 2011-12-13 | Gruenenthal Gmbh | Abuse-proofed dosage form |
| DE102004032051A1 (de) | 2004-07-01 | 2006-01-19 | Grünenthal GmbH | Verfahren zur Herstellung einer gegen Missbrauch gesicherten, festen Darreichungsform |
| DE102004032049A1 (de) | 2004-07-01 | 2006-01-19 | Grünenthal GmbH | Gegen Missbrauch gesicherte, orale Darreichungsform |
| DE102005005449A1 (de) | 2005-02-04 | 2006-08-10 | Grünenthal GmbH | Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform |
| DE102007011485A1 (de) | 2007-03-07 | 2008-09-11 | Grünenthal GmbH | Darreichungsform mit erschwertem Missbrauch |
| BRPI0906467C1 (pt) | 2008-01-25 | 2021-05-25 | Gruenenthal Gmbh | forma de dosagem farmacêutica com formato exterior modificado resistente à ruptura e com liberação controlada |
| KR101690094B1 (ko) | 2008-05-09 | 2016-12-27 | 그뤼넨탈 게엠베하 | 분무 응결 단계의 사용하에 중간 분말 제형 및 최종 고체 제형을 제조하는 방법 |
| US8058469B2 (en) * | 2008-11-03 | 2011-11-15 | Sabic Innovative Plastics Ip B.V. | Method for making carbamates, ureas and isocyanates |
| PE20121067A1 (es) | 2009-07-22 | 2012-09-05 | Gruenenthal Chemie | Forma de dosificacion de liberacion controlada extruida por fusion en caliente |
| WO2011009604A1 (fr) | 2009-07-22 | 2011-01-27 | Grünenthal GmbH | Forme galénique inviolable stabilisée à loxydation |
| EP2383255A1 (fr) | 2010-04-28 | 2011-11-02 | Lacer, S.A. | Nouveaux composés, synthèse et utilisation dans le traitement de la douleur |
| CA2808541C (fr) | 2010-09-02 | 2019-01-08 | Gruenenthal Gmbh | Forme pharmaceutique inviolable comportant un polymere anionique |
| WO2012028319A1 (fr) | 2010-09-02 | 2012-03-08 | Grünenthal GmbH | Forme pharmaceutique inviolable comportant un sel inorganique |
| EP2530072A1 (fr) | 2011-06-03 | 2012-12-05 | Lacer, S.A. | Nouveaux composés, synthèse et utilisation dans le traitement de la douleur |
| US10702485B2 (en) | 2011-07-09 | 2020-07-07 | Syntrix Biosystems Inc. | Compositions and methods for overcoming resistance to tramadol |
| KR20140053158A (ko) | 2011-07-29 | 2014-05-07 | 그뤼넨탈 게엠베하 | 즉시 약물 방출을 제공하는 탬퍼-저항성 정제 |
| AR087360A1 (es) | 2011-07-29 | 2014-03-19 | Gruenenthal Gmbh | Tableta a prueba de manipulacion que proporciona liberacion de farmaco inmediato |
| CA2864949A1 (fr) | 2012-02-28 | 2013-09-06 | Grunenthal Gmbh | Forme pharmaceutique inviolable comprenant un compose pharmacologiquement actif et un polymere anionique |
| JP6282261B2 (ja) | 2012-04-18 | 2018-02-21 | グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング | 不正使用防止および過量放出防止医薬剤形 |
| US10064945B2 (en) | 2012-05-11 | 2018-09-04 | Gruenenthal Gmbh | Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc |
| CA2913209A1 (fr) | 2013-05-29 | 2014-12-04 | Grunenthal Gmbh | Forme dosifiee inviolable a profil de liberation bimodale |
| EP3003279A1 (fr) | 2013-05-29 | 2016-04-13 | Grünenthal GmbH | Forme pharmaceutique inviolable contenant une ou plusieurs particules |
| AU2014289187B2 (en) | 2013-07-12 | 2019-07-11 | Grunenthal Gmbh | Tamper-resistant dosage form containing ethylene-vinyl acetate polymer |
| MX371372B (es) | 2013-11-26 | 2020-01-28 | Gruenenthal Gmbh | Preparacion de una composicion farmaceutica en polvo por medio de criomolienda. |
| CA2947786A1 (fr) | 2014-05-12 | 2015-11-19 | Grunenthal Gmbh | Formulation pour capsule a liberation immediate resistant aux manipulations illicites comprenant du tapentadol |
| JP2018517676A (ja) | 2015-04-24 | 2018-07-05 | グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング | 即時放出および溶媒抽出に対する耐性を有する改変防止製剤 |
| WO2017042325A1 (fr) | 2015-09-10 | 2017-03-16 | Grünenthal GmbH | Protection contre un surdosage par voie orale à l'aide de formulations à libération immédiate dissuasives d'abus |
| JP6824502B2 (ja) | 2015-10-15 | 2021-02-03 | ジエンス ヘンルイ メデイシンカンパニー リミテッドＪｉａｎｇｓｕ Ｈｅｎｇｒｕｉ Ｍｅｄｉｃｉｎｅ Ｃｏ．，Ｌｔｄ． | オキサスピロ誘導体、その製造方法、及び医薬におけるその適用 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1199764B (de) * | 1963-04-02 | 1965-09-02 | Gruenenthal Chemie | Verfahren zur Herstellung von basisch substituierten Phenolaethern |
| DE1518663A1 (de) | 1965-08-02 | 1969-12-18 | Gruenenthal Chemie | Basisch substituierte Cycloalken-derivate und Verfahren zu ihrer Herstellung |
| US3652589A (en) * | 1967-07-27 | 1972-03-28 | Gruenenthal Chemie | 1-(m-substituted phenyl)-2-aminomethyl cyclohexanols |
| US3562589A (en) * | 1968-09-09 | 1971-02-09 | Ite Imperial Corp | Electrically resetting undervoltage trip for circuit breakers |
| US5470885A (en) * | 1993-09-29 | 1995-11-28 | The Research Foundation Of The State University Of New York | Fluorocarbons as anti-inflammatory agents |
| DE19525137C2 (de) | 1995-07-11 | 2003-02-27 | Gruenenthal Gmbh | 6-Dimethylaminomethyl-1-phenyl-cyclohexanverbin -dungen als Zwischenprodukte zur Herstellung pharmazeutischer Wirkstoffe |
| ES2141688B1 (es) * | 1998-11-06 | 2001-02-01 | Vita Invest Sa | Nuevos esteres derivados de compuestos fenil-ciclohexil sustituidos. |
| GB9924604D0 (en) * | 1999-10-18 | 1999-12-22 | European Molecular Biology Lab Embl | Genetic switch |
-
1999
- 1999-12-30 ES ES200000060A patent/ES2160534B1/es not_active Expired - Fee Related
-
2000
- 2000-12-26 DE DE60016631T patent/DE60016631D1/de not_active Expired - Fee Related
- 2000-12-26 AT AT00983358T patent/ATE284380T1/de not_active IP Right Cessation
- 2000-12-26 WO PCT/ES2000/000486 patent/WO2001049650A1/fr not_active Application Discontinuation
- 2000-12-26 EP EP00983358A patent/EP1251120B1/fr not_active Expired - Lifetime
- 2000-12-26 SK SK925-2002A patent/SK9252002A3/sk unknown
- 2000-12-26 BR BR0016882-3A patent/BR0016882A/pt not_active IP Right Cessation
- 2000-12-26 IL IL15039200A patent/IL150392A0/xx unknown
- 2000-12-26 US US10/169,177 patent/US6894076B2/en not_active Expired - Fee Related
- 2000-12-26 EE EEP200200365A patent/EE200200365A/xx unknown
- 2000-12-26 CZ CZ20022189A patent/CZ20022189A3/cs unknown
- 2000-12-26 HU HU0204147A patent/HUP0204147A3/hu unknown
- 2000-12-26 CN CN00817916A patent/CN1414946A/zh active Pending
- 2000-12-26 AP APAP/P/2002/002571A patent/AP1234A/en active
- 2000-12-26 JP JP2001550190A patent/JP2003519208A/ja active Pending
- 2000-12-26 NZ NZ520263A patent/NZ520263A/en unknown
- 2000-12-26 OA OA1200200201A patent/OA12132A/en unknown
- 2000-12-26 MX MXPA02006514A patent/MXPA02006514A/es unknown
- 2000-12-26 EA EA200200614A patent/EA004770B1/ru not_active IP Right Cessation
- 2000-12-26 KR KR1020027008500A patent/KR20020063281A/ko not_active Application Discontinuation
- 2000-12-26 AU AU20126/01A patent/AU775918B2/en not_active Ceased
- 2000-12-26 YU YU50902A patent/YU50902A/sh unknown
- 2000-12-26 CA CA002395976A patent/CA2395976A1/fr not_active Abandoned
- 2000-12-26 PL PL00356056A patent/PL356056A1/xx unknown
-
2002
- 2002-06-24 MA MA26710A patent/MA26862A1/fr unknown
- 2002-06-25 IS IS6440A patent/IS6440A/is unknown
- 2002-06-26 NO NO20023098A patent/NO20023098L/no not_active Application Discontinuation
- 2002-06-27 ZA ZA200205193A patent/ZA200205193B/xx unknown
- 2002-06-27 HR HR20020559A patent/HRP20020559A2/hr not_active Application Discontinuation
- 2002-06-28 BG BG106883A patent/BG106883A/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL150392A0 (en) | Novel esters derived from (rr, ss)-2-(hydroxbenzoate of 3-(2-dimethylaminomethyl-1-hydroxyclohexyl) phenyl | |
| AU6900200A (en) | System for fabrication of indirect dental restoratives | |
| AU2115301A (en) | Dental compositions | |
| GB9918180D0 (en) | Novel compositions | |
| AU2611600A (en) | Dental cast tray assembly | |
| DE60008921D1 (en) | Kristalline form von (s)-2-ethoxy-3-4-(2-4-methansulfonyloxyphenyl-ethoxy)phenyl]propansäure | |
| AU6687900A (en) | Phenoxy fluoropyrimidines | |
| ZA200109206B (en) | Preparation of substituted piperidin-4-ones. | |
| AUPQ197899A0 (en) | Biomedical compositions | |
| EG24052A (en) | Novel processes for the preparation of (r)-a (2,3-demethoxyphenyl-1-(2-(4-fluorophenyl)ethyl)-4-piperidinemethapnol | |
| AU4991300A (en) | Processes for the synthesis of oligomers using phusphoramidite compositions | |
| AU1601801A (en) | Methods of preparing crna | |
| EP1072296A3 (fr) | Jeu vidéo | |
| AU6870600A (en) | Process for the preparation of 2,3-dihydroazepine compounds | |
| ITMI992048A0 (it) | Procedimento stereoselettivo per la preparazione di endo-3-amminoazabi cicloalcani | |
| GB0029650D0 (en) | Proces for the preparation of 1,1-cyclopropanedicarboxylic diesters | |
| AU6550800A (en) | Hepoxilin analogs | |
| AU3860600A (en) | Ceramic compositions | |
| AU6017900A (en) | Novel tumor suppressor gene | |
| AU2510101A (en) | The manufacture of improved support matrices | |
| IL144063A0 (en) | Process for the preparation of 1,1-cyclohexanediacetic acid | |
| AU4144900A (en) | Method of the utilization of bactericidal composition | |
| AU3158801A (en) | Novel vaccine composition | |
| AU2002232061A1 (en) | Compositions having improved bioavailability of eletriptan | |
| AUPP813299A0 (en) | Chemotherapeutic composition for the treatment of disease |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| HP | Change in proprietorship |